DocGo (NASDAQ:DCGO – Free Report) had its target price lowered by Needham & Company LLC to $1.00 in a report issued on Tuesday morning, Marketbeat.com reports. The brokerage currently has a buy rating on the stock.
Several other equities analysts have also recently commented on DCGO. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Canaccord Genuity Group reissued a “hold” rating and set a $1.00 price objective on shares of DocGo in a report on Tuesday, August 18th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, DocGo currently has a consensus rating of “Hold” and an average target price of $1.50.
View Our Latest Report on DocGo
DocGo Stock Performance
NASDAQ:DCGO opened at $0.23 on Tuesday. The firm’s 50-day moving average is $0.32 and its 200-day moving average is $0.55. DocGo has a 52-week low of $0.21 and a 52-week high of $1.10.
DocGo (NASDAQ:DCGO – Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.06). DocGo had a negative net margin of 60.96% and a negative return on equity of 63.66%. The company had revenue of $73.43 million for the quarter, compared to analyst estimates of $76.96 million. Sell-side analysts forecast that DocGo will post -0.40 earnings per share for the current year.
Hedge Funds Weigh In On DocGo
Hedge funds and other institutional investors have recently made changes to their positions in the business. S Squared Technology LLC acquired a new stake in shares of DocGo during the 2nd quarter valued at about $1,060,725. Renaissance Technologies LLC lifted its stake in DocGo by 167.1% during the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after purchasing an additional 944,826 shares during the period. BlackRock Inc. bought a new position in DocGo during the second quarter worth about $750,000. GSA Capital Partners LLP bought a new position in DocGo during the second quarter worth about $517,000. Finally, Marquette Asset Management LLC acquired a new stake in DocGo during the second quarter valued at approximately $175,000. 56.44% of the stock is owned by institutional investors.
DocGo Company Profile
DocGo Inc. (NASDAQ:DCGO) is a healthcare services company that delivers medical care and related support outside traditional healthcare facilities. Its platform combines mobile medical services, technology and logistics to help healthcare providers, government agencies and other organizations improve access to care. The company provides mobile health services that can include in-home and community-based clinical care, preventive services, diagnostic testing, vaccinations and care coordination. DocGo also offers remote patient monitoring and other technology-enabled services designed to support patients between healthcare visits and help manage ongoing conditions.
Further Reading
- Five stocks we like better than DocGo
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
